  | Moes, B., Li, H., Molina Ortiz, P., Radermecker, C., Rosu, A., Vande Catsyne, C.-A., Sayyed, S. A., Fontela Joao, Duque, M., Mostafa, A., Azzi, A., Barata Joao T., Merino Ramon, Xu, C., Desmet, C., & Schurmans, S. (2023). INPP5K controls the dynamic structure and signaling of wild type and mutated, leukemia-associated IL7 receptors. Blood, 141, 1708-1717. doi:10.1182/blood.2022017819  Peer Reviewed verified by ORBi |
 | Vande Catsyne, C.-A., Sayyed, S. A., Molina Ortiz, P., Moës, B., Communi, D., Muller, J., Heusschen, R., CAERS, J., Azzi, A., Erneux, C., & Schurmans, S. (2020). Altered chondrocyte differentiation, matrix mineralization and MEK-Erk1/2 signaling in an INPPL1 catalytic knock-out mouse model of opsismodysplasia. Advances in Biological Regulation, 76, 100651. doi:10.1016/j.jbior.2019.100651 Peer Reviewed verified by ORBi |
  | Sayyed, S. A., JOURET, F., Vermeersch, M., Pérez-Morga, D., & Schurmans, S. (2017). The lipid 5-phoshatase SHIP2 controls renal brush border ultrastructure and function by regulating ERM proteins activation. Kidney International. doi:10.1016/j.kint.2017.01.008 Peer Reviewed verified by ORBi |
 | Sayyed, S. A., Grosse, C., Steiger, K., & Heid, I. (2015). Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-14-2018 Peer Reviewed verified by ORBi |
 | Schurmans, S., Polizzi, S., Scoumanne, A., Sayyed, S. A., & Molina Ortiz, P. (2015). The Ras/Rap GTPase activating protein RASA3 : from gene structure to in vivo functions. Advances in Biological Regulation, 57, 153-161. doi:10.1016/j.jbior.2014.09.006 Peer Reviewed verified by ORBi |
 | Sayyed, S. A. (2011). Oral treatment with a chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney International, 80 (1), 68. Peer Reviewed verified by ORBi |
 | Sayyed, S. A. (2011). Mdm2 promotes systemic lupus erythematosus and lupus nephritis. Journal of the American Society of Nephrology, 22 (11), 2016. doi:10.1681/ASN.2011010045 Peer Reviewed verified by ORBi |
 | Sayyed, S. A. (2011). Dual blockade of the homeostatic chemokine CXCL12 and the pro-inflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. American Journal of Cardiology, 179 (1), 116. Peer Reviewed verified by ORBi |
 | Sayyed, S. A. (2010). Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. Nephrology Dialysis Transplantation, 25 (6), 1811. doi:10.1093/ndt/gfp730 Peer Reviewed verified by ORBi |
 | Sayyed, S. A. (2010). 4SC-101, A Novel Small Molecule Dihydroorotate Dehydrogenase Inhibitor, Suppresses Systemic Lupus Erythematosus in MRL-(Fas)lpr Mice. American Journal of Pathology, 176 (6), 2840. doi:10.2353/ajpath.2010.091227 Peer Reviewed verified by ORBi |
 | Sayyed, S. A. (2010). Podocytes express the homeostatic chemokine stromal cell-derived factor-1/CXCL12 which contributes to glomerulosclerosis, podocyte loss, and albuminuria in type 2 diabetes. Diabetologia, 52 (11), 2445. Peer Reviewed verified by ORBi |
 | Sayyed, S. A. (2010). Renal failure increases cardiac histone H3K9 and H3K23 acetylation, H3K4 dimethylation, phosphorylation at serine 10 and reduces the H3K9 dimethylation in type 2 diabetes. American Journal of Pathology, 176 (3), 1079. Peer Reviewed verified by ORBi |
 | Sayyed, S. A. (2009). Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in rat. Metabolism: Clinical and Experimental, 58 (3), 333. doi:10.1016/j.metabol.2008.10.005 Peer Reviewed verified by ORBi |
 | Sayyed, S. A. (2009). Questions about Chemokine and Chemokine Receptor Antagonism in Renal Inflammation. Nephron. Experimental Nephrology, 14 (2), 33. Peer Reviewed verified by ORBi |
 | Sayyed, S. A. (2009). 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice. Metabolism: Clinical and Experimental, 58 (10), 1503. doi:10.1016/j.metabol.2009.04.036 Peer Reviewed verified by ORBi |
 | Sayyed, S. A. (2006). Trolox ameliorates the nerve conduction velocity, nerve blood flow and nociception deficits in experimental diabetic neuropathy. Clinical and Experimental Pharmacology and Physiology. Supplement, 33 (11), 1022. Peer Reviewed verified by ORBi |
 | Sayyed, S. A. (2006). Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy. Life Sciences, 79 (8), 777. doi:10.1016/j.lfs.2006.02.033 Peer Reviewed verified by ORBi |